Non-stimulant ADHD medications, such as atomoxetine and guanfacine, provide effective alternatives to stimulants, addressing ...

He is currently on the medication Guanfacine. Ms McAnish said: "Unlike some medications that can be started or stopped at will, it's specifically advised not to stop [Guanfacine] abruptly." ...

and guanfacine. Atomoxetine, which is usually marketed under the brand name Strattera, was the first non-stimulant ADHD medication to be approved by the FDA in 2002. It isn't clear how atomoxetine ...

Owing to the rarity of SHINE syndrome, physicians at the Precision Medicine Institute of the ... the tool suggested guanfacine, a drug commonly used to control high blood pressure, as a treatment ...

Onyda XR contains an ER formulation of clonidine. It is FDA-approved to treat ADHD alone or in combination with a stimulant ...

A new Review article series, “AI in Medicine,” explores the role of AI technology in clinical medicine and digital health, and examines the promise and pitfalls of its application across the ...

The page includes both the generic and brand names and can serve as an invaluable resource for healthcare professionals and individuals who wish to get an insight on different medication options.

One of the advantages of being a family medicine practitioner is that, unlike other doctors, physicians in this field aren't limited to treating a particular health condition or a specific type of ...

Apr. 30, 2024 — A genetic propensity to higher circulating levels of lipids containing arachidonic acid, an omega-6 polyunsaturated fatty acid found in eggs, poultry, and seafood, has been found ...

The Correspondence section provides a forum for discussion or to present a point of view on issues that are of interest to the readership of Nature Medicine. Correspondences should not contain new ...